Krystal Biotech, Inc. (KRYS) insider trading

By person

10 insiders · 572 transactions

1,296×

Krish S. Krishnan holds 1,296 times base salary in stock. $1.10B of shares against $846.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Krish S. Krishnan last reported holding, valued at $366.56, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Krish S Krishnan

President and CEO

$2.05M (3)

$135.71M (226) scheduled

−$133.66M

2,993,408

10.11%

$1.10B

−16.9%

Suma Krishnan

President, R&D

$1.78M (5)

$135.36M (232) scheduled

−$133.58M

2,993,408

10.11%

$1.10B

−18.2%

Daniel Janney

Director

$2.00M (1)

$44.01M (38) scheduled

−$42.01M

73,293

0.2476%

$26.87M

−24.1%

Dino A Rossi

Director

—

$16.51M (11)

−$16.51M

50,000

0.1689%

$18.33M

—

Kathryn Romano

Chief Accounting Officer

—

$12.67M (44) scheduled

−$12.67M

22,366

0.0756%

$8.20M

—

Julian S Gangolli

Director

—

$3.28M (3) scheduled

−$3.28M

0.0000%

$0.00

—

Andrew C. Orth

Chief Commercial Officer

—

$1.61M (3) scheduled

−$1.61M

100

0.0003%

$36.66K

0.0%

John Charles Thomas

EVP, General Counsel

—

$541.17K (2) scheduled

−$541.17K

0.0000%

$0.00

−100.0%

R Douglas Norby

Director

$93.78K (1)

—

+$93.78K

9,000

0.0304%

$3.30M

—

Antony A Riley

Chief Financial Officer

$30.10K (1)

—

+$30.10K

9,050

0.0306%

$3.32M

—

Krystal Biotech, Inc.

What the insiders did Net selling

By person